+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review

  • ID: 4267304
  • SWOT Analysis
  • December 2020
  • 51 pages
  • GlobalData

FEATURED COMPANIES

  • ARUP Laboratories
  • Becton Dickinson and Co
  • Cepheid Inc
  • Eurofins Genomics GmbH
  • Nanosphere Inc
  • Quest Diagnostics Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi drug resistant organisms (MDROs). OpGen’s develops products that include QuickFISH, and PNA FISH products, Acuitas molecular diagnostic, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments

Dec 09, 2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11, 2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15, 2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05, 2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ARUP Laboratories
  • Becton Dickinson and Co
  • Cepheid Inc
  • Eurofins Genomics GmbH
  • Nanosphere Inc
  • Quest Diagnostics Inc
Section 1 - About the Company
  • OpGen Inc - Key Facts
  • OpGen Inc - Key Employees
  • OpGen Inc - Key Employee Biographies
  • OpGen Inc - Major Products and Services
  • OpGen Inc - History
  • OpGen Inc - Company Statement
  • OpGen Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • OpGen Inc - Business Description
  • Product Category: Collaboration Revenue
  • Overview
  • Performance
  • Product Category: Laboratory Services
  • Overview
  • Performance
  • Product Category: Product Sales
  • Overview
  • Performance
  • R&D Overview
  • OpGen Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • OpGen Inc - Strengths
  • OpGen Inc - Weaknesses
  • OpGen Inc - Opportunities
  • OpGen Inc - Threats
  • OpGen Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • OpGen Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Dec 09, 2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
  • Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
  • Nov 11, 2020: OpGen reports third quarter 2020 financial results and provides business update
  • Oct 15, 2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
  • Oct 05, 2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud
  • Sep 30, 2020: OpGen announces award of German Government grant funding to its subsidiary Curetis and collaborators
  • Sep 16, 2020: Collaborative research by OpGen Group company ares genetics and Johns Hopkins researchers demonstrates potential of next-generation sequencing for investigation of genetic antimicrobial resistance mechanisms and molecular susceptibility testing
  • Aug 12, 2020: OpGen reports second quarter 2020 financial results and provides business update
  • Jul 15, 2020: OpGen provides business update and announces preliminary unaudited revenue and cash position for second quarter 2020
  • Jul 13, 2020: Menarini Silicon Biosystems partners with OpGen to broaden distribution of CELLSEARCH platform in North America
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • OpGen Inc, Key Facts
  • OpGen Inc, Key Employees
  • OpGen Inc, Key Employee Biographies
  • OpGen Inc, Major Products and Services
  • OpGen Inc, History
  • OpGen Inc, Subsidiaries
  • OpGen Inc, Key Competitors
  • OpGen Inc, Ratios based on current share price
  • OpGen Inc, Annual Ratios
  • OpGen Inc, Interim Ratios
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • OpGen Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • OpGen Inc, Performance Chart (2015 - 2019)
  • OpGen Inc, Ratio Charts
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Accelerate Diagnostics Inc
  • ARUP Laboratories
  • AutoGenomics Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Cepheid Inc
  • Curetis NV
  • Eurofins Genomics GmbH
  • GenMark Diagnostics Inc
  • Laboratory Corp of America Holdings
  • Nanosphere Inc
  • Pathnostics
  • Quest Diagnostics Inc
  • T2 Biosystems Inc
Note: Product cover images may vary from those shown
Adroll
adroll